CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $326,000 | -27.2% | 273,233 | +10.0% | 0.00% | – |
Q2 2022 | $448,000 | -80.1% | 248,408 | -77.7% | 0.00% | – |
Q1 2022 | $2,248,000 | -28.9% | 1,112,586 | -4.6% | 0.00% | -100.0% |
Q4 2021 | $3,161,000 | -37.1% | 1,166,363 | +3.4% | 0.00% | 0.0% |
Q3 2021 | $5,029,000 | -19.1% | 1,127,648 | +5.2% | 0.00% | 0.0% |
Q2 2021 | $6,219,000 | -9.1% | 1,072,209 | +10.0% | 0.00% | 0.0% |
Q1 2021 | $6,845,000 | +46.5% | 974,926 | +0.1% | 0.00% | 0.0% |
Q4 2020 | $4,672,000 | -20.3% | 973,476 | -3.2% | 0.00% | 0.0% |
Q3 2020 | $5,865,000 | -13.1% | 1,005,963 | +0.6% | 0.00% | -50.0% |
Q2 2020 | $6,746,000 | +53.1% | 999,488 | +44.2% | 0.00% | +100.0% |
Q1 2020 | $4,407,000 | -33.3% | 692,980 | +9.3% | 0.00% | 0.0% |
Q4 2019 | $6,611,000 | +167.1% | 634,225 | +0.7% | 0.00% | 0.0% |
Q3 2019 | $2,475,000 | -73.5% | 629,717 | +0.2% | 0.00% | -50.0% |
Q2 2019 | $9,350,000 | -40.0% | 628,766 | +0.1% | 0.00% | -50.0% |
Q1 2019 | $15,588,000 | +39.0% | 628,025 | +0.6% | 0.00% | +33.3% |
Q4 2018 | $11,215,000 | -38.8% | 624,455 | +0.1% | 0.00% | -25.0% |
Q3 2018 | $18,329,000 | -34.1% | 624,102 | +2.1% | 0.00% | -42.9% |
Q2 2018 | $27,803,000 | -5.7% | 611,459 | +9.5% | 0.01% | -12.5% |
Q1 2018 | $29,472,000 | -22.4% | 558,193 | +0.0% | 0.01% | -20.0% |
Q4 2017 | $37,957,000 | -19.6% | 558,175 | -2.5% | 0.01% | -16.7% |
Q3 2017 | $47,195,000 | -4.5% | 572,755 | +8.6% | 0.01% | -14.3% |
Q2 2017 | $49,398,000 | +59.5% | 527,608 | +8.5% | 0.01% | +55.6% |
Q1 2017 | $30,969,000 | +65.3% | 486,400 | +15.3% | 0.01% | +50.0% |
Q4 2016 | $18,734,000 | +27.7% | 421,756 | +3.7% | 0.01% | +20.0% |
Q3 2016 | $14,667,000 | +174.0% | 406,813 | +4.2% | 0.01% | +150.0% |
Q2 2016 | $5,353,000 | -21.6% | 390,230 | +14.3% | 0.00% | 0.0% |
Q1 2016 | $6,826,000 | -41.3% | 341,336 | +2.7% | 0.00% | -50.0% |
Q4 2015 | $11,630,000 | -61.1% | 332,299 | +2.1% | 0.00% | -60.0% |
Q3 2015 | $29,933,000 | +20.0% | 325,497 | +14.7% | 0.01% | +25.0% |
Q2 2015 | $24,941,000 | +14.8% | 283,812 | -3.1% | 0.01% | +14.3% |
Q1 2015 | $21,733,000 | +34.6% | 292,785 | +1.6% | 0.01% | +40.0% |
Q4 2014 | $16,141,000 | +19.8% | 288,231 | -3.0% | 0.01% | +25.0% |
Q3 2014 | $13,476,000 | +25.1% | 297,108 | +14.2% | 0.00% | +33.3% |
Q2 2014 | $10,769,000 | -42.4% | 260,070 | -3.6% | 0.00% | -50.0% |
Q1 2014 | $18,683,000 | +7.8% | 269,720 | -6.2% | 0.01% | 0.0% |
Q4 2013 | $17,329,000 | +17.7% | 287,532 | +18.8% | 0.01% | +20.0% |
Q3 2013 | $14,719,000 | +2.5% | 242,083 | +12.9% | 0.01% | 0.0% |
Q2 2013 | $14,363,000 | – | 214,453 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |